The Interaction Between Heparin and Plasmin on Amidolysis

Summary

The effect of the interaction between heparin and plasmin not only on fibrinolytic, caseinolytic and esterolytic activities but also on amidolytic activity, since plasmin has amidolytic or amidase activity, was investigated.

Following were the results obtained from these investigations:

1. Heparin enhanced amidolytic activity of a fixed level of plasmin which was prepared by activating plasminogen with urokinase within the range from 2 to 64 units/ml of the final concentration of heparin

2. Heparin also enhanced amidolytic activity of a fixed level of plasmin which was prepared by converting plasminogen with insolubilized urokinase.

3. Heparin did not enhance or inhibit fibrinolytic, caseinolytic and esterolytic activities of a fixed level of plasmin which was prepared by activating plasminogen with urokinase, in the fibrinolytic activity within the range from 0.032 to 125 units/ml, in the caseinolytic activity within the range from 0.0125 to 100 units/ml, and in the esterolytic activity within the range from 0.016 to 128 units/ml, of the final concentration of heparin respectively.

• References

• 1 Abiko Y, Iwamoto M, Tomikawa M. 1969; Plasminogen - Plasmin System V. A Stoichiometric Equilibrium Complex of Plasminogen and a Synthetic Inhibitor. Biochemica et Biophysica Acta 185: 424
• 2 Bang NU, Beller FK, Deutsch E, Mammen EF. 1971. Thrombosis and Bleeding Disorders. Georg Thieme Verlag, Stuttgart Academic Press; New York, London: p 357
• 3 Barlow GH, Summaria L, Robbins KC. 1969; Molecular Weight Studies on Human Plasminogen and Plasmin at the Microgram Level. The Journal of Biological Chemistry 244: 1138
• 4 Biggs R, Denson KW E, Akman N, Borret R, Hadden M. 1970; Antithrombin III, Antifactor X_a and Heparin. British Journal of Haematology 19: 283
• 5 Brockway WJ, Castellino FJ. 1972; Measurement of the Binding of Antifibrinolytic Amino Acids to Various Plasminogens. Archives of Biochemistry and Biophysics 151: 194
• 6 Deutsch DG, Mertz ET. 1970; Plasminogen: Purification from Human Plasma by Affinity Chromatography. Science 170: 1095
• 7 Erlanger BF, Kokowsky N, Cohen W. 1961; The Preparation and Properties of Two New Chromogenic Substrates of Trypsin. Archives of Biochemistry and Biophysics 95: 271
• 8 Hestrin S. 1949; The Reaction of Acetylcholine and Other Carboxylic Acid Derivatives with Hydroxylamine, and Its Analytical Application. The Journal of Biological Chemistry 180: 249
• 9 Nagasawa S. 1975 Personal communication.
• 10 Roberts PS. 1958; Measurement of the Rate of Plasmin Action on Synthetic Substrates. The Journal of Biological Chemistry 232: 285
• 11 Rosenberg RD. 1974; The Effect of Heparin on Factor XI_a and Plasmin. Thrombosis et Diathesis Haemorrhagica (Stuttg.) 33: 51
• 12 Seegers HW, Cole HR, Harmison CR, Monkhouse FC. 1964; Neutralization of Autoprothrombin C Activity with Antithrombin. Canadian Journal of Biochemistry 42: 359
• 13 Sherry S, Alkjaersig N, Fletcher AP. 1964; Assay of Urokinase Preparations with the Synthetic Substrate Acetyl-L-Lysine Methyl Ester. Journal of Laboratory and Clinical Medicine 64: 145
• 14 Stead N, Kaplan AP, Rosenberg RD. 1976; Inhibition of activated Factor XII by Antithrombin-Heparin Cofactor. The Journal of Biological Chemistry 251: 3694
• 15 Walton PL. 1967; The Hydrolysis of α-N-Acetylglycyl-L-Lysine Methyl Ester by Urokinase. Biochemica et Biophysica Acta 132: 104
• 16 Wiman B, Wallen P. 1973; Activation of Human Plasminogen by an Insoluble Derivative of Urokinase. European Journal of Biochemistry 36: 25
• 17 Yasukouchi T, Watanabe T. 1972; A New Method based on One Dimensional Diffusion using Small Glass Tubes for the Measurement of Fibrinolytic Activity. I. Fibrinolytic Activity of Plasmin and “Euglobulin + Streptokinase”. Thrombosis et Diathesis Haemorrhagica (Stuttg.) 28: 329
• 18 Yasukouchi T, Fujine M, Kohn S, Sakurama S, Morioka T, Mikami A, Iju M, Nakagawa S. 1977; A Method for the Measurement of Fibrinolytic Activity based on One Dimensional Diffusion using Small Glass Tubes. II. With Special Reference to the Differences between the Use of Plasminogen-rich Fibrinogen and that of Plasminogen-free Fibrinogen as the Substrates. Thrombosis and Haemostasis (Stuttg.) 35: 456
• 19 Yin ET, Wessler S, Stoll PJ. 1971; Rabbit Plasma Inhibitor of the Activated Species of Blood Coagulation Factor X: Purification and some Properties. The Journal of Biological Chemistrv 246: 3694